Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback